/ Not yet recruitingPhase 1 一项在中国健康成人受试者中评价多次口服苯磺酸CG-0255胶囊的药效动力学特征、药代动力学特征、安全性和耐受性的I期、开放性临床研究
[Translation] A Phase I, open-label clinical study to evaluate the pharmacodynamics, pharmacokinetic characteristics, safety and tolerability of CG-0255 besylate capsules after repeated oral administration in healthy Chinese adult subjects
在中国健康成人受试者中评估多次口服苯磺酸CG-0255胶囊的药效动力学(PD)特征;
在中国健康成人受试者中评估多次口服苯磺酸CG-0255胶囊的药代动力学(PK)特征;
[Translation] To evaluate the pharmacodynamic (PD) characteristics of CG-0255 benzenesulfonic acid capsules after multiple oral administration in healthy Chinese adult subjects;
To evaluate the pharmacokinetic (PK) characteristics of CG-0255 benzenesulfonic acid capsules after multiple oral administration in healthy Chinese adult subjects;
100 Clinical Results associated with Shang Hai Ke Jin Zi Xun Guan Li You Xian Gong Si
0 Patents (Medical) associated with Shang Hai Ke Jin Zi Xun Guan Li You Xian Gong Si
100 Deals associated with Shang Hai Ke Jin Zi Xun Guan Li You Xian Gong Si
100 Translational Medicine associated with Shang Hai Ke Jin Zi Xun Guan Li You Xian Gong Si